Lighthouse Investment Partners LLC Sells 33,277 Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Lighthouse Investment Partners LLC decreased its stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 84.7% during the second quarter, according to the company in its most recent filing with the SEC. The fund owned 6,000 shares of the company’s stock after selling 33,277 shares during the period. Lighthouse Investment Partners LLC’s holdings in GE HealthCare Technologies were worth $468,000 as of its most recent filing with the SEC.

A number of other institutional investors have also made changes to their positions in GEHC. 9258 Wealth Management LLC raised its holdings in GE HealthCare Technologies by 5.7% in the 4th quarter. 9258 Wealth Management LLC now owns 3,273 shares of the company’s stock worth $253,000 after acquiring an additional 176 shares during the period. TD Asset Management Inc increased its stake in shares of GE HealthCare Technologies by 5.4% in the fourth quarter. TD Asset Management Inc now owns 249,514 shares of the company’s stock worth $19,292,000 after purchasing an additional 12,684 shares during the period. TFO Wealth Partners LLC lifted its position in shares of GE HealthCare Technologies by 520.9% during the 4th quarter. TFO Wealth Partners LLC now owns 3,297 shares of the company’s stock worth $255,000 after purchasing an additional 2,766 shares during the last quarter. Dorsey & Whitney Trust CO LLC boosted its stake in GE HealthCare Technologies by 21.4% during the 4th quarter. Dorsey & Whitney Trust CO LLC now owns 5,885 shares of the company’s stock valued at $455,000 after purchasing an additional 1,038 shares during the period. Finally, Bank of Nova Scotia grew its holdings in GE HealthCare Technologies by 29.4% in the 4th quarter. Bank of Nova Scotia now owns 48,847 shares of the company’s stock valued at $3,777,000 after buying an additional 11,103 shares during the last quarter. 82.06% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

A number of brokerages recently issued reports on GEHC. Redburn Atlantic raised shares of GE HealthCare Technologies to a “strong-buy” rating in a research report on Thursday, August 1st. UBS Group lowered shares of GE HealthCare Technologies from a “neutral” rating to a “sell” rating and cut their price objective for the company from $84.00 to $74.00 in a research report on Thursday. BTIG Research upgraded shares of GE HealthCare Technologies from a “neutral” rating to a “buy” rating and set a $100.00 target price for the company in a research note on Wednesday, September 18th. JPMorgan Chase & Co. began coverage on GE HealthCare Technologies in a research note on Monday, September 9th. They set a “neutral” rating and a $90.00 price target on the stock. Finally, Stifel Nicolaus started coverage on GE HealthCare Technologies in a research report on Tuesday, August 6th. They issued a “buy” rating and a $100.00 price objective for the company. One research analyst has rated the stock with a sell rating, five have given a hold rating, seven have given a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $93.92.

Insider Activity at GE HealthCare Technologies

In other GE HealthCare Technologies news, CEO Thomas J. Westrick sold 2,750 shares of the company’s stock in a transaction on Wednesday, August 7th. The stock was sold at an average price of $80.78, for a total transaction of $222,145.00. Following the transaction, the chief executive officer now owns 17,509 shares of the company’s stock, valued at approximately $1,414,377.02. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. 0.27% of the stock is currently owned by company insiders.

GE HealthCare Technologies Trading Down 0.5 %

Shares of GEHC opened at $91.99 on Monday. The company has a debt-to-equity ratio of 1.05, a quick ratio of 0.82 and a current ratio of 1.06. The company has a market cap of $41.99 billion, a price-to-earnings ratio of 26.90, a PEG ratio of 3.40 and a beta of 1.17. The stock has a fifty day moving average price of $85.13 and a two-hundred day moving average price of $83.22. GE HealthCare Technologies Inc. has a 52-week low of $62.35 and a 52-week high of $94.55.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings results on Wednesday, July 31st. The company reported $1.00 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.98 by $0.02. GE HealthCare Technologies had a net margin of 8.10% and a return on equity of 25.26%. The business had revenue of $4.84 billion for the quarter, compared to the consensus estimate of $4.88 billion. During the same quarter in the prior year, the company earned $0.92 EPS. The firm’s quarterly revenue was up .5% on a year-over-year basis. Analysts predict that GE HealthCare Technologies Inc. will post 4.26 EPS for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, November 15th. Stockholders of record on Friday, October 18th will be paid a dividend of $0.03 per share. The ex-dividend date is Friday, October 18th. This represents a $0.12 annualized dividend and a dividend yield of 0.13%. GE HealthCare Technologies’s dividend payout ratio (DPR) is currently 3.51%.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.